{"version":"1.0","type":"rich","width":1200,"height":675,"title":"p-tau217: Del Biomarcador Plasmático a la Decisión Clínica","description":"Resolución interactiva de un caso clínico sobre el uso de p-tau217 plasmática en la enfermedad de Alzheimer. Evalúa la interpretación de resultados y la toma de decisiones diagnósticas mediante biomarcadores sanguíneos para un abordaje clínico preciso y precoz.","author_name":"Genially","provider_name":"Genially","provider_url":"https://genially.com","html":"<div style='width: 100%;'><div style='position: relative; padding-bottom:56.25%; padding-top: 0; height: 0;'><iframe frameborder='0' width='1200' height='675' style='position:absolute; top: 0; left: 0; width: 100%; height: 100%;' src='https://view.genially.com/6a09e5fc55c0fefb4c7c856a' type='text/html' allowscriptaccess='always' allowfullscreen='true' scrolling='yes' allownetworking='all'></iframe></div></div>","thumbnail_url":"https://genially-thumbnails.genially.com/6a09e5fc55c0fefb4c7c856a.png?ts=1779048667257","thumbnail_width":1200,"thumbnail_height":675}